AgingResearch.News
BMJ Medicine

Comparative efficacy and safety of glucagon-like peptide 1 based drugs for weight loss in adults with overweight or obesity without diabetes: network meta-analysis of randomised controlled trials

By Deshi Chen, Bing Ma, Hao Sun, Show 10 more authorsYongze Li
Figure 1. Flowchart of selection of studies included in the network meta-analysis, based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
Open the figure at full size
Figure 1. Flowchart of selection of studies included in the network meta-analysis, based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)Flowchart of selection of studies included in the network meta-analysis, based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)Chen et al.
Meta-analysis of randomised trialsInterventions

12 weeks, preregistered CRD420261279841, declared no competing interests

Paper

The paper

Deshi Chen, Bing Ma, Hao Sun, Show 10 more authorsYongze Li

First Hospital of China Medical University

BMJ Medicine, 27 Aug 2026

doi.org/10.1136/bmjmed-2026-003026PubMed 42688617

More on GLP-1 and incretin signalling